Literature DB >> 18979391

A cross-sectional assessment of utilization of addiction treatment among injection drug users in Kabul, Afghanistan.

Catherine S Todd1, Abdullah M S Abed, Paul T Scott, Naqibullah Safi, Kenneth C Earhart, Steffanie A Strathdee.   

Abstract

The purpose of this study was to describe prior use of detoxification and addiction-treatment programs among injection drug users (IDUs) in Kabul, Afghanistan. From 2005-2006, IDUs (n = 464) recruited into this cross-sectional study completed an interviewer-administered questionnaire and whole blood rapid testing with fingerstick samples for HIV, syphilis, and hepatitis C antibody and B surface antigen testing. Participants were predominantly male (99.8%), Afghan (98.9%), and had little formal education. Correlates of detoxification and addiction treatment were identified with logistic regression. The majority (94.0%, n = 435) felt great/urgent need for treatment, of whom 56.3% (n = 245) reported inability to access treatment. Prior detoxification was associated with new needle use with each injection (AOR = 1.91, 95% CI: 1.12-3.26) and prior incarceration (AOR = 1.81, 95% CI: 1.04-3.13). The study's limitations are noted. Rapid scale-up and subsidy of needle and syringe programs and opioid agonist treatment is urgently needed in Kabul.

Entities:  

Mesh:

Year:  2009        PMID: 18979391      PMCID: PMC7153687          DOI: 10.1080/10826080802347669

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  19 in total

1.  Evaluating effectiveness of syringe exchange programmes: current issues and future prospects.

Authors:  F I Bastos; S A Strathdee
Journal:  Soc Sci Med       Date:  2000-12       Impact factor: 4.634

2.  Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment. The Manif 2000 study group.

Authors:  J P Moatti; M P Carrieri; B Spire; J A Gastaut; J P Cassuto; J Moreau
Journal:  AIDS       Date:  2000-01-28       Impact factor: 4.177

3.  Opioid substitution and HIV/AIDS treatment and prevention.

Authors:  Thomas Kerr; Alex Wodak; Richard Elliott; Julio S Montaner; Evan Wood
Journal:  Lancet       Date:  2004 Nov 27-Dec 3       Impact factor: 79.321

4.  The prevalence of injecting drug use in a Russian city: implications for harm reduction and coverage.

Authors:  Lucy Platt; Matthew Hickman; Tim Rhodes; Larissa Mikhailova; Victor Karavashkin; Alexander Vlasov; Kate Tilling; Vivian Hope; Mikhail Khutorksoy; Adrian Renton
Journal:  Addiction       Date:  2004-11       Impact factor: 6.526

Review 5.  Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence.

Authors:  Alex Wodak; Annie Cooney
Journal:  Subst Use Misuse       Date:  2006       Impact factor: 2.164

6.  Do drug users in China who frequently receive detoxification treatment change their risky drug use practices and sexual behavior?

Authors:  Hongjie Liu; Oscar Grusky; Yibin Zhu; Xiaojing Li
Journal:  Drug Alcohol Depend       Date:  2006-01-26       Impact factor: 4.492

7.  Complex emergencies, HIV, and substance use: no "big easy" solution.

Authors:  Steffanie A Strathdee; Julie A Stachowiak; Catherine S Todd; Wael K Al-Delaimy; Wayne Wiebel; Catherine Hankins; Thomas L Patterson
Journal:  Subst Use Misuse       Date:  2006       Impact factor: 2.164

Review 8.  The HIV epidemic in China: history, response, and challenge.

Authors:  Na He; Roger Detels
Journal:  Cell Res       Date:  2005 Nov-Dec       Impact factor: 25.617

9.  Methadone maintenance and addicts' risk of fatal heroin overdose.

Authors:  J R Caplehorn; M S Dalton; F Haldar; A M Petrenas; J G Nisbet
Journal:  Subst Use Misuse       Date:  1996-01       Impact factor: 2.164

10.  Effectiveness of harm reduction programmes for injecting drug users in Dhaka city.

Authors:  Tasnim Azim; Najmul Hussein; Robert Kelly
Journal:  Harm Reduct J       Date:  2005-10-25
View more
  5 in total

Review 1.  Determinants of health among people who use illicit drugs in the conflict-affected countries of Afghanistan, Colombia and Myanmar: a systematic review of epidemiological evidence.

Authors:  Sally O'Brien; Margarita Marin Jaramillo; Bayard Roberts; Lucy Platt
Journal:  Confl Health       Date:  2022-07-07       Impact factor: 4.554

2.  Successful testing and treating of HIV/AIDS in Indonesia depends on the addiction treatment modality.

Authors:  Shelly Iskandar; Cor Aj de Jong; Teddy Hidayat; Ike Mp Siregar; Tri H Achmad; Reinout van Crevel; Andre van der Ven
Journal:  J Multidiscip Healthc       Date:  2012-12-14

3.  Prevalence and correlates of HIV, syphilis, and hepatitis B and C infection and harm reduction program use among male injecting drug users in Kabul, Afghanistan: A cross-sectional assessment.

Authors:  Catherine S Todd; Abdul Nasir; M Raza Stanekzai; Katja Fiekert; M Zafar Rasuli; David Vlahov; Steffanie A Strathdee
Journal:  Harm Reduct J       Date:  2011-08-25

Review 4.  Factors Associated with HIV Risk and Vulnerability Among Injecting Drug Users in Afghanistan: A Narrative Review.

Authors:  Ahmad Shekaib Rasikh
Journal:  HIV AIDS (Auckl)       Date:  2022-07-23

Review 5.  Understanding injecting drug use in Afghanistan: A scoping review.

Authors:  Frishta Nafeh; Sufiat Fusigboye; Bundit Sornpaisarn
Journal:  Subst Abuse Treat Prev Policy       Date:  2022-09-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.